Cargando…

COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far

Humans have witnessed three deadly pandemics so far in the twenty-first century which are associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and COVID-19. All of these viruses, which are responsible for causing acute respiratory tract infections (ARTIs), are highly c...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mujeeb, Adil, Syed F., Alkhathlan, Hamad Z., Tahir, Muhammad N., Saif, Sadia, Khan, Merajuddin, Khan, Shams T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795815/
https://www.ncbi.nlm.nih.gov/pubmed/33374759
http://dx.doi.org/10.3390/molecules26010039
_version_ 1783634533678055424
author Khan, Mujeeb
Adil, Syed F.
Alkhathlan, Hamad Z.
Tahir, Muhammad N.
Saif, Sadia
Khan, Merajuddin
Khan, Shams T.
author_facet Khan, Mujeeb
Adil, Syed F.
Alkhathlan, Hamad Z.
Tahir, Muhammad N.
Saif, Sadia
Khan, Merajuddin
Khan, Shams T.
author_sort Khan, Mujeeb
collection PubMed
description Humans have witnessed three deadly pandemics so far in the twenty-first century which are associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and COVID-19. All of these viruses, which are responsible for causing acute respiratory tract infections (ARTIs), are highly contagious in nature and/or have caused high mortalities. The recently emerged COVID-19 disease is a highly transmittable viral infection caused by another zoonotic novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to the other two coronaviruses such as SARS-CoV-1 and MERS-CoV, SARS-CoV-2 is also likely to have originated from bats, which have been serving as established reservoirs for various pathogenic coronaviruses. Although, it is still unknown how SARS-CoV-2 is transmitted from bats to humans, the rapid human-to-human transmission has been confirmed widely. The disease first appeared in Wuhan, China, in December 2019 and quickly spread across the globe, infected 48,539,872 people, and caused 1,232,791 deaths in 215 countries, and the infection is still spreading at the time of manuscript preparation. So far, there is no definite line of treatment which has been approved or vaccine which is available. However, different types of potential vaccines and therapeutics have been evaluated and/or are under clinical trials against COVID-19. In this review, we summarize different types of acute respiratory diseases and briefly discuss earlier outbreaks of coronaviruses and compare their occurrence and pathogenicity with the current COVID-19 pandemic. Various epidemiological aspects of COVID-19 such as mode of spread, death rate, doubling time, etc., have been discussed in detail. Apart from this, different technical issues related to the COVID-19 pandemic including use of masks and other socio-economic problems associated with the pandemic have also been summarized. Additionally, we have reviewed various aspects of patient management strategies including mechanism of action, available diagnostic tools, etc., and also discussed different strategies for the development of effective vaccines and therapeutic combinations to deal with this viral outbreak. Overall, by the inclusion of various references, this review covers, in detail, the most important aspects of the COVID-19 pandemic.
format Online
Article
Text
id pubmed-7795815
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77958152021-01-10 COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far Khan, Mujeeb Adil, Syed F. Alkhathlan, Hamad Z. Tahir, Muhammad N. Saif, Sadia Khan, Merajuddin Khan, Shams T. Molecules Review Humans have witnessed three deadly pandemics so far in the twenty-first century which are associated with novel coronaviruses: SARS, Middle East respiratory syndrome (MERS), and COVID-19. All of these viruses, which are responsible for causing acute respiratory tract infections (ARTIs), are highly contagious in nature and/or have caused high mortalities. The recently emerged COVID-19 disease is a highly transmittable viral infection caused by another zoonotic novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to the other two coronaviruses such as SARS-CoV-1 and MERS-CoV, SARS-CoV-2 is also likely to have originated from bats, which have been serving as established reservoirs for various pathogenic coronaviruses. Although, it is still unknown how SARS-CoV-2 is transmitted from bats to humans, the rapid human-to-human transmission has been confirmed widely. The disease first appeared in Wuhan, China, in December 2019 and quickly spread across the globe, infected 48,539,872 people, and caused 1,232,791 deaths in 215 countries, and the infection is still spreading at the time of manuscript preparation. So far, there is no definite line of treatment which has been approved or vaccine which is available. However, different types of potential vaccines and therapeutics have been evaluated and/or are under clinical trials against COVID-19. In this review, we summarize different types of acute respiratory diseases and briefly discuss earlier outbreaks of coronaviruses and compare their occurrence and pathogenicity with the current COVID-19 pandemic. Various epidemiological aspects of COVID-19 such as mode of spread, death rate, doubling time, etc., have been discussed in detail. Apart from this, different technical issues related to the COVID-19 pandemic including use of masks and other socio-economic problems associated with the pandemic have also been summarized. Additionally, we have reviewed various aspects of patient management strategies including mechanism of action, available diagnostic tools, etc., and also discussed different strategies for the development of effective vaccines and therapeutic combinations to deal with this viral outbreak. Overall, by the inclusion of various references, this review covers, in detail, the most important aspects of the COVID-19 pandemic. MDPI 2020-12-23 /pmc/articles/PMC7795815/ /pubmed/33374759 http://dx.doi.org/10.3390/molecules26010039 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Khan, Mujeeb
Adil, Syed F.
Alkhathlan, Hamad Z.
Tahir, Muhammad N.
Saif, Sadia
Khan, Merajuddin
Khan, Shams T.
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
title COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
title_full COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
title_fullStr COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
title_full_unstemmed COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
title_short COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
title_sort covid-19: a global challenge with old history, epidemiology and progress so far
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795815/
https://www.ncbi.nlm.nih.gov/pubmed/33374759
http://dx.doi.org/10.3390/molecules26010039
work_keys_str_mv AT khanmujeeb covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar
AT adilsyedf covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar
AT alkhathlanhamadz covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar
AT tahirmuhammadn covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar
AT saifsadia covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar
AT khanmerajuddin covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar
AT khanshamst covid19aglobalchallengewitholdhistoryepidemiologyandprogresssofar